Investigations into the Signaling Pathways Involving Glucose-Stimulated Zinc Secretion (GSZS) from Prostate...

Area of Science:

• Biochemistry
• Cell Biology
• Metabolic Pathways

Background:

• High glucose exposure in prostate cells triggers zinc ion release, a process termed glucose-stimulated zinc secretion (GSZS).
• The precise metabolic triggers for GSZS remain largely uncharacterized.
• Understanding these pathways is crucial for prostate health research.

Purpose of the Study:

• To investigate the metabolic events and signaling pathways that initiate glucose-stimulated zinc secretion (GSZS).
• To explore the role of glucose metabolism in triggering zinc release from prostate cells in vitro and in vivo.
• To differentiate the effects of glucose from other metabolites like pyruvate and deoxyglucose on GSZS.

Main Methods:

• Utilized PNT1A prostate epithelial cells and rat prostate models.
• Monitored zinc secretion using optical methods (ZIMIR) and MRI.
• Assessed expression levels of GLUT1, GLUT4, and Akt.
• Administered glucose, deoxyglucose, pyruvate, GLUT1 inhibitor (WZB-117), and insulin receptor inhibitor (S961) to investigate GSZS mechanisms.

Main Results:

• PNT1A cells secreted zinc upon high glucose exposure, but not with deoxyglucose or pyruvate.
• Akt expression was sensitive to zinc levels, while GLUT1 and GLUT4 were less affected by glucose.
• In vivo, GLUT1 inhibition reduced GSZS, while insulin receptor inhibition had no effect.
• Pyruvate and deoxyglucose stimulated in vivo zinc secretion indirectly, suggesting gluconeogenesis.

Conclusions:

• Glucose metabolism, specifically glycolytic flux, is essential for triggering GSZS in prostate cells and in vivo.
• Pyruvate can stimulate GSZS in vivo indirectly through glucose production via gluconeogenesis.
• These findings elucidate key metabolic requirements for glucose-stimulated zinc secretion in the prostate.